Quick answers about GLP-1 medication costs
Common cost questions answered before you go deeper.
GLP-1 medication costs vary significantly by drug, dose, insurance coverage, pharmacy, and any applicable savings programs. Without insurance, branded GLP-1 medications commonly range from approximately $800 to over $1,400 per month at list price. Actual out-of-pocket cost can be substantially lower with insurance coverage or manufacturer savings programs — or higher if additional provider, lab, and program fees apply. Always verify current pricing with the manufacturer or your pharmacy.
It depends on your plan and the indication. Many insurance plans cover GLP-1 medications prescribed for type 2 diabetes (such as Ozempic and Mounjaro), often with prior authorization. Coverage for GLP-1 medications prescribed for weight management (such as Wegovy and Zepbound) is less consistent — some plans cover it, many exclude it. Medicare Part D generally does not cover drugs approved only for weight loss. See our GLP-1 insurance coverage guide for a full breakdown.
Wegovy's list price varies by dose and changes over time. Without insurance or a savings program, it can cost over $1,300 per month at list price. Novo Nordisk offers savings programs that may reduce costs for eligible commercially insured patients — but eligibility requirements apply and the programs are not available to patients with government insurance. Verify current Wegovy pricing directly with the manufacturer or your pharmacy. See our Wegovy cost guide for more detail.
Zepbound's list price varies by dose. Without insurance or a savings program, it can cost over $1,000 per month at list price. Eli Lilly offers savings programs and self-pay vial options that may be available to eligible patients — eligibility requirements apply. Verify current Zepbound pricing at the Lilly official pricing page or with your pharmacy. See our Zepbound cost guide for more detail.
Compounded GLP-1 preparations are often priced lower than branded products, but they are not FDA-approved alternatives. Compounded semaglutide is not a generic version of Ozempic or Wegovy, and compounded tirzepatide is not a generic version of Mounjaro or Zepbound. The FDA has issued warnings about risks associated with compounded GLP-1 products, including inconsistent potency, dosing errors, and misleading marketing. See our compounded GLP-1 guide for more.
Online GLP-1 program costs vary by provider and structure. Total cost typically includes a consultation or membership fee, the medication itself (which may or may not be covered by insurance), lab work (required by some programs), and ongoing follow-up visits. Some programs quote medication cost only; others bundle all fees. Always compare total program cost — not just the advertised price — before committing. See how online GLP-1 prescriptions work for a process overview.
No. Manufacturer savings programs have eligibility requirements, annual limits, and terms that change over time. They are generally not available to patients using government insurance such as Medicare or Medicaid. Always verify current savings program terms directly with the manufacturer or your pharmacist — do not rely on third-party claims about savings card availability or value.
What affects the cost of GLP-1 medications?
Multiple independent variables determine your actual out-of-pocket cost — no single factor tells the full story.
No two patients pay the same amount for a GLP-1 medication. The list price of the drug is just the starting point. What you actually pay is shaped by a combination of the factors below — and how those factors interact with each other. Understanding them helps you ask the right questions before committing to a program or provider.
Which medication is prescribed
Different GLP-1 drugs have different list prices. Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus, and Saxenda each carry distinct prices by dose and formulation.
Your insurance plan
Whether your plan covers the prescribed drug — and at what tier — is one of the biggest determinants of cost. Diabetes indications are more commonly covered than weight-management indications.
Indication and diagnosis
The medical reason for prescribing affects insurance coverage. Ozempic for type 2 diabetes may be covered where the same drug prescribed off-label for weight loss is not. Your clinician documents the indication.
Prior authorization
Many insurance plans require prior authorization before covering GLP-1 medications. PA approval is not guaranteed and typically requires clinical documentation. Failed PA can mean paying list price or appealing.
Dose and device
GLP-1 medications are available in multiple dose strengths. Higher doses typically carry higher list prices. Your clinician determines the appropriate starting dose based on your clinical situation, not a cost preference.
Provider and program fees
Telehealth programs charge consultation, membership, or visit fees in addition to medication cost. These vary widely by program — some bundle all fees, others add them separately. Always ask for the total cost breakdown.
Required lab work
Some programs require baseline bloodwork (A1C, metabolic panel, thyroid) before prescribing. Lab costs may be covered by insurance separately, included in program fees, or billed independently. Ask up front.
Pharmacy source and shipping
Pharmacy choice — retail, mail-order, or specialty — affects medication price. Some programs partner with specific pharmacies. Shipping fees may or may not be included in the program price.
Savings programs
Manufacturer savings programs may significantly reduce out-of-pocket costs for eligible patients — but eligibility requirements apply. Government insurance recipients are generally not eligible. Terms change over time.
GLP-1 medication cost comparison
Approximate list price ranges for reference only — actual cost depends on insurance, dose, and savings program eligibility.
| Medication | Active Ingredient | FDA Indication | Approx. List Price / Month | Manufacturer Pricing Page |
|---|---|---|---|---|
| Wegovy | Semaglutide injection | Chronic weight management | ~$1,300–$1,450 (varies by dose) | Novo Nordisk pricing Wegovy cost guide → |
| Zepbound | Tirzepatide injection | Chronic weight management | ~$1,000–$1,100 (varies by dose) | Lilly pricing Zepbound cost guide → |
| Ozempic | Semaglutide injection | Type 2 diabetes | ~$800–$1,000 (varies by dose) | Novo Nordisk pricing |
| Mounjaro | Tirzepatide injection | Type 2 diabetes | ~$1,000–$1,100 (varies by dose) | Lilly pricing |
| Rybelsus | Semaglutide oral tablet | Type 2 diabetes | ~$850–$1,000 (varies by dose) | Novo Nordisk |
| Saxenda | Liraglutide injection | Chronic weight management | ~$1,300–$1,500 (varies by dose) | Novo Nordisk |
Sources: Manufacturer pricing pages (Novo Nordisk, Eli Lilly). Prices shown are approximate list prices as of the time of writing and are subject to change. They are not quotes, guarantees, or offers. Verify current pricing directly with the manufacturer or a licensed pharmacy.
Does insurance cover GLP-1 medications?
Coverage depends on your plan, the medication, and the indication — there is no universal answer.
Insurance coverage for GLP-1 medications is one of the most commonly misunderstood aspects of access and cost. The same medication may be covered under one plan and excluded entirely from another. The indication (the reason it was prescribed) is one of the most important factors. For a full guide, see our GLP-1 insurance coverage guide.
🩺 Type 2 diabetes indication
GLP-1 medications prescribed for type 2 diabetes (Ozempic, Mounjaro, Rybelsus) are more commonly covered by commercial insurance plans. Prior authorization is frequently required, and coverage varies by formulary and plan. Most employer-sponsored health plans include some coverage for diabetes medications.
⚖️ Weight management indication
GLP-1 medications prescribed for weight management (Wegovy, Zepbound, Saxenda) face inconsistent coverage. Many commercial plans exclude weight-loss drugs. Some employer plans have added obesity coverage — but many have not. Coverage is improving but is not universal. Always check your specific benefit before starting.
🏛️ Medicare and Medicaid
Medicare Part D traditionally excluded drugs approved only for weight loss — this is changing with new legislation, but coverage is still limited. Medicare may cover GLP-1 medications for diabetes indications. Medicaid coverage varies significantly by state. Manufacturer savings programs are generally not available to Medicare or Medicaid recipients.
📄 Prior authorization requirements
Prior authorization (PA) is a common requirement for GLP-1 medications. PA requires your clinician to submit clinical documentation demonstrating medical necessity. PA is not guaranteed to be approved, and the process can take days to weeks. Some telehealth programs offer PA support — ask about this before enrolling.
Off-label prescribing and coverage: Some providers prescribe medications for indications other than those on the FDA label (off-label use). Insurance coverage for off-label prescriptions can be denied even if the drug is otherwise covered for its FDA-approved indication. Your clinician should document the appropriate indication — and you should understand how this affects your coverage before starting any program.
How much do GLP-1s cost without insurance?
List price, cash-pay programs, savings programs, and total cost are four different numbers — understand the difference.
When evaluating the cost of a GLP-1 without insurance, four separate figures can apply: the list price (what the drug costs before any discounts), the cash-pay price some pharmacies offer, savings program pricing (for eligible patients), and the total program price (which includes provider fees, labs, and other costs). Comparing programs on any single figure without understanding what is included gives an incomplete picture.
List price
The manufacturer's suggested retail price. This is the starting point — not necessarily what you pay. Pharmacies may discount or mark up from list price. Without insurance or savings programs, this is often close to what you will pay at a retail pharmacy.
Cash-pay / self-pay pricing
Some pharmacies offer lower cash-pay prices on certain medications or dosing formats. Eli Lilly, for example, has offered Zepbound self-pay vials at different price points than pen injectors. These programs have eligibility and availability limitations — verify directly with the manufacturer or pharmacy.
Manufacturer savings programs
Savings programs offered directly by Novo Nordisk (for Wegovy, Ozempic) and Eli Lilly (for Zepbound, Mounjaro) can significantly reduce out-of-pocket cost for eligible commercially insured patients. Eligibility requirements, annual limits, and program terms change — always verify directly with the manufacturer.
Total program cost
When using a telehealth program, add all fees: consultation/membership, medication, lab work, shipping, and follow-up visits. A program advertising a low medication price may have significant additional fees. Always ask for a full cost breakdown before enrolling.
What online GLP-1 programs typically charge for
The medication is rarely the only cost — understand what each line item covers before committing to a program.
Licensed telehealth programs vary significantly in how they structure and disclose their fees. Some charge a flat monthly fee that bundles most costs; others quote medication cost only and add fees for each additional service. Before enrolling, ask for a complete breakdown of every cost you may incur. See our online GLP-1 programs comparison and online GLP-1 prescription guide for program-by-program context.
👩⚕️ Consultation fee
The cost of the initial clinician evaluation. Some programs charge a one-time intake fee; others roll it into a membership. May be required even if you are not ultimately prescribed.
🔄 Membership / subscription fee
Ongoing monthly or quarterly platform fees separate from medication cost. These cover clinician access, messaging, and platform support. Ask whether you can pause or cancel, and what the cancellation terms are.
💊 Medication cost
The price of the GLP-1 medication itself — from a licensed pharmacy. This may or may not be covered by insurance. If insurance is used, prior authorization may apply. If cash-pay, ask which pharmacy and whether savings program terms apply.
🧪 Lab work fees
Some programs require baseline labs (A1C, metabolic panel, lipids) before prescribing and ongoing labs during treatment. These may be billed separately, included in the program fee, or covered by insurance. Always ask what labs are required and who pays.
📦 Shipping and dispensing
Some programs include shipping in their fee; others add it. Shipping costs for temperature-sensitive injectables can vary. Ask about shipping costs, packaging, and handling for your location.
🔁 Follow-up visits
Ongoing clinician check-ins are part of responsible GLP-1 treatment. Some programs include follow-up in membership fees; others charge per visit. Adequate follow-up is important for safety and side effect management.
🛡️ Side effect support
Ask whether the program has a clinical team available if you experience side effects. Programs that can't support you through side effects or dose adjustments may not be the right fit. See our GLP-1 safety guide.
📋 Insurance support / PA assistance
Some programs assist with insurance prior authorization documentation. This can be valuable if you have coverage that requires PA. Ask whether this service is included — and whether the program accepts insurance at all.
Savings cards and manufacturer programs
Savings programs can meaningfully reduce cost — but eligibility is not universal and terms change.
Novo Nordisk (manufacturer of Wegovy and Ozempic) and Eli Lilly (manufacturer of Zepbound and Mounjaro) each offer savings and patient assistance programs. These programs can significantly reduce out-of-pocket costs for eligible patients — but they are not available to everyone, and their terms change over time. The following is a high-level educational summary only. Always verify current terms directly with the manufacturer or your pharmacist.
✅ Who may be eligible
Savings programs are typically available to commercially insured US residents. Patients must be using the medication for an approved indication. Some programs have income thresholds. Requirements vary by program and change over time — verify directly with the manufacturer.
🚫 Who is typically excluded
Patients using government insurance (Medicare, Medicaid, TRICARE, VA) are generally not eligible for manufacturer savings programs. Patients who are uninsured may qualify for patient assistance programs rather than savings card programs — ask the manufacturer directly.
📅 Annual limits and expiration
Most savings programs cap total annual savings and may expire mid-year if the limit is reached. Terms including the savings amount, annual cap, and eligible pharmacies are set by the manufacturer and are subject to change without notice.
🔍 How to verify current terms
Do not rely on third-party websites or online programs for current savings program terms. Go directly to the manufacturer: NovoNordisk/NovoCare for Wegovy and Ozempic, and Lilly pricing pages for Zepbound and Mounjaro.
No savings program guarantees a specific price. Any program, advertisement, or website that promises you a specific dollar figure for a GLP-1 medication — without verifying your insurance status and eligibility — is not providing accurate information. Verify directly with the manufacturer or a licensed pharmacist before making any decision based on a quoted price.
Are compounded GLP-1 medications cheaper?
Often yes — but compounded products are not FDA-approved alternatives to branded GLP-1 medications.
Compounded semaglutide and compounded tirzepatide have been marketed and sold at prices significantly below those of branded FDA-approved GLP-1 medications. While the lower price point attracts attention, it is important to understand that compounded GLP-1 preparations are not the same as their branded counterparts and carry different regulatory status and associated risks. For a full discussion, see our compounded GLP-1 guide and GLP-1 medications without a prescription guide.
Not FDA-approved
Compounded GLP-1 preparations are not FDA-approved for safety, efficacy, or consistent potency. They have not undergone the clinical trial process required of FDA-approved medications like Ozempic, Wegovy, Mounjaro, or Zepbound.
Not a generic or equivalent
Compounded semaglutide is not a generic version of Ozempic or Wegovy. Compounded tirzepatide is not a generic version of Mounjaro or Zepbound. FDA-approved generics require a full regulatory approval process that has not occurred for these drugs.
Potency and dosing inconsistency
The FDA has flagged concerns about inconsistent potency, dosing errors, and misleading marketing with compounded GLP-1 products. The lack of FDA oversight means quality can vary between batches and compounding pharmacies.
Changing regulatory status
As national GLP-1 drug shortages resolve, the FDA has clarified that compounding restrictions apply when drugs are no longer on the shortage list. The regulatory status of compounded GLP-1 products has been in flux — verify current FDA guidance before using any compounded product.
FDA warnings about compounded GLP-1 products
The FDA has issued multiple warnings relevant to compounded GLP-1 preparations:
- Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not the same as branded GLP-1 medications.
- The FDA has expressed serious concerns about unapproved GLP-1 drugs used for weight loss, including risks from dosing errors and potency inconsistencies.
- The FDA warned 30 telehealth companies against the illegal marketing of compounded GLP-1 medications.
- Products labeled "for research use only" are not intended for human use and pose serious health risks.
See: compounded GLP-1 medications | GLP-1 medications without a prescription
Safe GLP-1 cost comparison checklist
Before choosing an online GLP-1 program based on price, verify these eight criteria.
Price is one factor in evaluating an online GLP-1 program — but safety, clinical quality, and transparency matter at least as much. A lower-priced program that shortcuts clinical evaluation, uses unapproved medications, or hides fees is not a better deal. Use the following checklist when evaluating any program you are considering.
- Licensed clinician evaluation. The program must include a real clinical evaluation by a licensed clinician — not an automated intake that bypasses clinical review. See our eligibility guide.
- Prescription required. No legitimate program dispenses prescription GLP-1 medications without a valid prescription from a licensed clinician. Walk away from any program that skips this step.
- FDA-approved medication or clear disclosure. The medication should be FDA-approved and sourced from a licensed US pharmacy — or any deviation from this must be clearly disclosed and understood. Ask specifically about the source of the medication.
- Transparent total fee breakdown. Request a complete breakdown of all fees before enrolling: consultation, membership, medication, labs, shipping, and follow-up visits. Do not rely on advertised headline prices alone.
- Pharmacy sourcing transparency. Confirm where the medication is dispensed — it should be a licensed US pharmacy. Programs using overseas suppliers, unlicensed pharmacies, or compounding pharmacies without clear disclosure warrant scrutiny.
- Ongoing follow-up care. GLP-1 treatment requires ongoing monitoring. Ask how the program handles follow-up visits, dose adjustments, and ongoing clinical questions — and whether these are included in the fee.
- Side effect support. Ask whether clinical support is available if you experience side effects. See our side effects guide and safety guide for what to watch for.
- Clear cancellation terms. Understand exactly how to pause or cancel the program, whether there are cancellation fees, and what happens to any unused medication or prepaid services if you stop.
READY TO COMPARE PROGRAMS?
Compare Safe Online GLP-1 Programs
Our comparison guide reviews licensed telehealth programs by prescription process, medication transparency, total cost structure, follow-up care, and safety practices. All programs listed require a real clinician review — no shortcuts, no guaranteed approvals, no unapproved medications.
Prescription treatment is available only if a licensed clinician determines it is medically appropriate for your situation. This page is educational and is not medical advice.
Sources
Pricing and regulatory claims on this page are based on the following official sources. List prices are subject to change — verify current pricing directly with the manufacturer.
- Eli Lilly — Zepbound Official Pricing Information
- Eli Lilly — Mounjaro Official Pricing Information
- Novo Nordisk / NovoCare — Ozempic List Price Explanation
- Novo Nordisk / NovoCare — Wegovy Price Guide (PDF)
- FDA — Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- FDA — Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s